Tennessee Oncology Executive and Leadership Team

Ronald Horowitz, the Chief Financial Officer at Tennessee Oncology, manages the fiscal health and capital allocation strategies for the organization. Horowitz oversees revenue cycle management, ensuring the financial viability of specialized oncology services across all regional clinics. By analyzing market trends in cancer care, the Chief Financial Officer develops long-term investment plans for advanced medical technology and facility expansion. Ronald Horowitz collaborates with the executive team to balance physician-owned practice requirements with the need for sustainable growth. This leadership role involves monitoring reimbursement landscapes and optimizing billing operations to support patient education and support services. Through precise financial forecasting, Horowitz mitigates economic risks associated with the evolving healthcare sector. The Chief Financial Officer drives fiscal discipline, allowing the practice to reinvest in innovative treatments and patient-centered care initiatives. By maintaining robust financial controls, Horowitz ensures the organization remains a leader in providing comprehensive cancer care throughout the service area.

Bill Alexander, the Chief Operating Officer at Tennessee Oncology, directs the daily administrative functions across 30 clinical locations. Alexander manages the complex logistics of outpatient chemotherapy delivery and laboratory services to ensure seamless patient access. By optimizing resource allocation within the physician-owned practice, the Chief Operating Officer maintains high standards of operational efficiency. Alexander coordinates with regional managers to standardize nursing care protocols throughout Middle Tennessee and Northwest Georgia. This leadership role involves streamlining PET/CT service workflows to reduce wait times for cancer patients. Through rigorous oversight of facility infrastructure, Bill Alexander supports the broader mission of providing accessible, high-quality oncology care. The Chief Operating Officer continuously evaluates clinical throughput metrics to identify areas for process improvement. By aligning operational capacity with patient demand, Alexander secures the long-term sustainability of the practice while upholding the commitment to excellence in cancer treatment delivery.

Natalie Dickson, the President & Chief Strategy Officer at Tennessee Oncology, defines the long-term vision and market positioning for the organization. Dickson drives strategic growth initiatives, expanding the reach of cancer care services into new regional markets across the Southeast. By identifying opportunities for service line diversification, the President & Chief Strategy Officer ensures the practice remains at the forefront of oncology innovation. Natalie Dickson coordinates with the Board and executive leadership to align organizational goals with the evolving needs of cancer patients. This leadership role involves cultivating partnerships that enhance patient education and support services. Through proactive market analysis, Dickson anticipates shifts in the healthcare landscape and adjusts the corporate strategy accordingly. The President & Chief Strategy Officer champions the physician-owned model, reinforcing the commitment to patient-centered care. By setting the strategic direction, Dickson empowers the entire organization to deliver superior clinical results while maintaining a competitive edge in the oncology sector.

Casey Chollet-Lipscomb, the Chief Medical Officer at Tennessee Oncology, architects the clinical standards and treatment protocols for the entire physician network. Chollet-Lipscomb oversees the quality of oncology nursing care and ensures adherence to evidence-based practices across all 30 locations. By leading clinical research initiatives and integrating innovative therapies, the Chief Medical Officer improves patient outcomes throughout Middle Tennessee and Northwest Georgia. Casey Chollet-Lipscomb facilitates collaboration among the 75 physicians to maintain a unified approach to complex cancer cases. This leadership role involves evaluating the efficacy of outpatient chemotherapy programs and diagnostic services. Through the implementation of advanced medical guidelines, Chollet-Lipscomb elevates the standard of care provided to every patient. The Chief Medical Officer monitors clinical performance metrics to ensure consistent delivery of high-quality oncology services. By fostering a culture of continuous learning and medical excellence, Chollet-Lipscomb strengthens the reputation of the practice as a premier destination for cancer treatment.